Inovio Pharmaceuticals, Inc. share price logo

Inovio Pharmaceuticals, Inc. Share Price

NASDAQ: INO

Small Cap

$1.69

+0.06

(+3.68%)

as on

Inovio Pharmaceuticals, Inc. Stock Performance

as on March 18, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $1.63
    $1.72
    downward going graph

    3.55%

    Downside

    1.78%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.30
    $2.98
    downward going graph

    23.08%

    Downside

    76.27%

    Upside

    downward going graph

Inovio Pharmaceuticals, Inc. share price movements today

Previous Close
$1.63
Open
$1.65
Volume
999.7K
Day's Low - High
$1.63 - $1.72
52 Week Low - High
$1.30 - $2.98

Inovio Pharmaceuticals, Inc. Historical Returns

1 Month Return
0 %
3 Month Return
-37.31 %
1 Year Return
-22.75 %
3 Year Return
-87.54 %
5 Year Return
-98.71 %

Inovio Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Check Inovio Pharmaceuticals, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$112.0M

EPS (TTM)

-1.125

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.56

Industry PE ratio

-3.725551724137931

PEG Ratio

0

EBITDA

-85.4M

Revenue (TTM)

65.3K

Profit Margin

0.00%

Return On Equity TTM

-183.47%

Inovio Pharmaceuticals, Inc. Stock Valuation

Track how Inovio Pharmaceuticals, Inc. P/E has moved over time to understand its valuation trends.

Inovio Pharmaceuticals, Inc. in the last 5 years

  • Overview

  • Trends

Lowest (-139.20x)

June 30, 2021

Industry (-3.73x)

March 17, 2026

Today (-1.56x)

March 17, 2026

Highest (-0.63x)

March 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -1.56x

Inovio Pharmaceuticals, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Inovio Pharmaceuticals, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Inovio Pharmaceuticals, Inc. image
Inovio Pharmaceuticals, Inc.
BUY$112.0M-98.71%-1.560.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.6B119.71%135.098.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$119.2B114.71%30.6832.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$32.8BNA1155.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$78.8B52.6%17.9931.41%

Stock Returns calculator for Inovio Pharmaceuticals, Inc. Stock including INR - Dollar returns

The Inovio Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Inovio Pharmaceuticals, Inc. investment value today

Current value as on today

₹86,633

Returns

₹13,367

(-13.37%)

Returns from Inovio Pharmaceuticals, Inc. Stock

₹19,905 (-19.91%)

Dollar Returns*

₹6,539 (+6.54%)

Analyst Recommendation on Inovio Pharmaceuticals, Inc. Stock

Based on 9 analysts

BUY

55.56%

Buy

44.44%

Hold

0.00%

Sell

Based on 9 analysts, 55.56% of analysts recommend a 'BUY' rating for Inovio Pharmaceuticals, Inc.. Average target price of $7.63

Inovio Pharmaceuticals, Inc. Share Price Target

Get share price movements and forecasts by analysts on Inovio Pharmaceuticals, Inc..

What analysts predicted

77.85%UPSIDE

Target Price

$7.63

Current Price

$1.69

Analyzed by

9 Analysts

Target

$7.63

Inovio Pharmaceuticals, Inc. target price $7.63, a slight upside of 77.85% compared to current price of $1.69. According to 9 analysts rating.

Inovio Pharmaceuticals, Inc. Stock’s Investor Sentiment and Interest

Search interest for Inovio Pharmaceuticals, Inc. Stock has increased by 81% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:81% versus previous 30 day period

Inovio Pharmaceuticals, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
0
0
-
0
-
0
0
-
-
0
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-35
-27
-31
-33
-27
-20
-25
-23
-21
-17
EBITDA
-32
-24
-29
-31
-24
-18
-25,050
-22
-44
-16
Interest Expense
0
0
0
-
-
-
-
-
-
-
Depreciation
1
0
0
0
0
0
0
0
0
-
Income Before Tax
-33
-25
-30
-32
-25
-19
-19
-23
-45
3
Income Tax Expense
-1
0
0
0
-
0
-
-
-
-
Net Income
-33
-25
-30
-32
-25
-19
-19
-23
-45
3
Net Profit Margin
-8734.77%
-24357.91%
0.00%
-31993.31%
0.00%
-16566.39%
-30140.48%
0.00%
0.00%
-5761.72%

Inovio Pharmaceuticals, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
35
42
30
4
7
1
10
0
0
0
Gross Profit
35
42
30
4
7
1
10
0
-2
-2
Operating Income
-76
-83
-94
-111
-124
-301
-267
-143
-112
-86
EBITDA
-74
-84
-89
-107
-149
-296
-270
-130
-103
-83
Interest Expense
0
0
0
7
8
1
1
1
0
-
Depreciation
-
3
4
5
4
4
5
4
3
-
Income Before Tax
-73
-88
-94
-120
-167
-303
-279
-135
-107
-84
Income Tax Expense
-4
1
2
0
52
0
2
0
-107,146
-
Net Income
-73
-88
-96
-119
-166
-303
-279
-135
-107
-84
Net Profit Margin
-208.49%
-208.92%
-318.12%
-2902.75%
-2245.39%
-17109.87%
-2726.67%
-16239.87%
-49254.27%
-130000.00%

Inovio Pharmaceuticals, Inc. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-25
-30
-32
-87
-19
-19
-23
-45
23,439
Operating Cash Flow
-26
-28
-28
-84
-19
-26
-20
-21
-19
Investing Cash Flow
19
45
9
69,371
34
0
5
8
0
Financing Cash Flow
1
-11
33
0
29
1
0
24
27
Change in Cash
-4
5
14
-12
44
-25
-15
12
7,705

Inovio Pharmaceuticals, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-88
-96
-120
-167
-303
-279
-135
-107
-84,945
Operating Cash Flow
-63
-73
-97
-177
-215
-216
-124
-104
-88,629
Investing Cash Flow
-27
42
-9
-58
-175
109
87
104
14,039
Financing Cash Flow
95
31
105
465
211
81
4
51
53,050
Change in Cash
4
0
-1
228
-179
-24
-32
51
-21,539

Global Institutional Holdings in Inovio Pharmaceuticals, Inc.

Funds
Holdings
HHG PLC
4.73%
Citadel Advisors Llc
0.32%
Boxer Capital Management, LLC
3.51%
Bank of America Corp
0.92%
Goldman Sachs Group Inc
0.26%
See all

Insights on Inovio Pharmaceuticals, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -45.49M → 3.76M (in $), with an average increase of 1308.5% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 26.0% return, outperforming this stock by 48.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 72.0% return, outperforming this stock by 159.5%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 116.99K → -65.34K (in $), with an average decrease of 122.1% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, INO stock has moved down by -37.3%

About Inovio Pharmaceuticals, Inc.

inovio is revolutionizing the fight against cancer and infectious diseases. our immunotherapies uniquely activate best-in-class immune responses to prevent and treat disease, and have shown clinically significant efficacy with a favorable safety profile. with an expanding portfolio of immune therapies, the company is advancing a growing preclinical and clinical stage product pipeline. partners and collaborators include roche, medimmune, university of pennsylvania, darpa, drexel university, nih, hiv vaccines trial network, national cancer institute, u.s. military hiv research program, and university of manitoba. for more information, visit www.inovio.com.
OrganisationInovio Pharmaceuticals, Inc.
Headquarters660 West Germantown Pike, Plymouth Meeting, PA, United States, 19462
IndustryHealth Technology
CEODr. Jacqueline E. Shea Ph.D.
E-voting on sharesClick here to vote

Key Management of Inovio Pharmaceuticals, Inc.

Name

Title

Dr. Jeffrey Skolnik

Senior Vice President of Clinical Development

Mr. Robert J. Juba Jr.

Senior Vice President of Biological Manufacturing & Clinical Supply Management

Mr. Peter D. Kies

Chief Financial Officer

Mr. E. J. Brandreth MBA

Senior Vice President of Quality Assurance

Dr. Laurent M. Humeau Ph.D.

Chief Scientific Officer & Chairman of the Scientific Advisory Board

Thomas Hong

Manager of Investor Relations

Mr. Robert L. Crotty J.D.

General Counsel, Corporate Secretary & Chief Compliance Officer

Ms. Jennie Willson

Director of Communications

Dr. Jacqueline E. Shea Ph.D.

CEO, President & Director

Dr. Michael Sumner B.S., M.B.A., M.D.

Chief Medical Officer & Head of Development

FAQs

What is Inovio Pharmaceuticals, Inc. share price today?

Inovio Pharmaceuticals, Inc. share price today is $1.69 as on at the close of the market. Inovio Pharmaceuticals, Inc. share today touched a day high of $1.72 and a low of $1.63.

What is the 52 week high and 52 week low for Inovio Pharmaceuticals, Inc. share?

Inovio Pharmaceuticals, Inc. share touched a 52 week high of $2.98 on and a 52 week low of $1.3 on . Inovio Pharmaceuticals, Inc. stock price today i.e. is closed at $1.69,which is 43.27% down from its 52 week high and 30.00% up from its 52 week low.

What is Inovio Pharmaceuticals, Inc.'s market capitalisation today?

Inovio Pharmaceuticals, Inc. market capitalisation is $0.00T as on .

How to invest in Inovio Pharmaceuticals, Inc. Stock (INO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Inovio Pharmaceuticals, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Inovio Pharmaceuticals, Inc. Shares that will get you 0.8876 shares as per Inovio Pharmaceuticals, Inc. share price of $1.69 per share as on March 18, 2026 at 1:29 am IST.

What is the minimum amount required to buy Inovio Pharmaceuticals, Inc. Stock (INO) from India?

Indian investors can start investing in Inovio Pharmaceuticals, Inc. (INO) shares with as little as ₹92.369 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹923.69 in Inovio Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Inovio Pharmaceuticals, Inc. share’s latest price of $1.69 as on March 18, 2026 at 1:29 am IST, you will get 5.9172 shares of Inovio Pharmaceuticals, Inc.. Learn more about fractional shares .

What are the returns that Inovio Pharmaceuticals, Inc. has given to Indian investors in the last 5 years?

Inovio Pharmaceuticals, Inc. stock has given -98.71% share price returns and 27.14% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?